BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6396561)

  • 1. [Phase II study of the treatment of CML blast crisis with vindesine and prednisone].
    Jehn U; Mezger J
    Onkologie; 1984 Dec; 7(6):342-5. PubMed ID: 6396561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U; Mezger J
    Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
    Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
    Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
    Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
    [No Abstract]   [Full Text] [Related]  

  • 6. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
    Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
    Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vindesine effect in myeloid leukemia.
    Baccarani M; Zaccaria A; Corbelli G; Tura S
    Cancer Chemother Pharmacol; 1982; 8(3):255-9. PubMed ID: 6957273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of chronic myelogenous leukemia in blastic crisis--vindesine, cytosine arabinoside prednisolone combination therapy].
    Uzuka Y; Saito Y; Takahash H; Komatsu M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1064-70. PubMed ID: 6586112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the blastic crisis of chronic myelogenous leukemia with the combination of vindesine and prednisolone, and cytosine arabinoside.
    Uzuka Y; Saito Y
    Tohoku J Exp Med; 1983 Apr; 139(4):419-20. PubMed ID: 6575487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphoid blast crisis in chronic myelogenous leukemia].
    Ranft K
    Dtsch Med Wochenschr; 1984 Jan; 109(1):20-3. PubMed ID: 6581956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
    Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
    Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
    Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
    Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II study of Vindesine in patients with hematological malignancy].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
    Bayssas M; Gouveia J; Ribaud P; Musset M; de Vassal F; Pico JL; de Luca L; Misset JL; Machover D; Belpomme D; Schwarzenberg L; Jasmin C; Hayat M; Mathé G
    Cancer Chemother Pharmacol; 1979; 2(4):247-55. PubMed ID: 287569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of chronic myelogenous leukemia in blastic crisis with the chemotherapy incorporating vindesine-prednisolone.
    Saito Y; Uzuka Y; Takahashi H; Komatsu M; Ito T
    Tohoku J Exp Med; 1986 Jan; 148(1):65-72. PubMed ID: 3458333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.